Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/<i>DICER1</i> Registries

Outcomes were worse for patients with FIGO stage ≥IC2 disease and for tumors with >19 mitoses per 10 HPF. Given the prognostic significance of MI, the authors strongly recommend the assessment of MI for all juvGCTs. More information about tumor biology is critical to identify which patients may benefit from adjuvant chemotherapy and to facilitate the development of novel therapies.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2025-04-23
DOI
https://doi.org/10.1002/cncr.35862
Citations
3
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
5.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries

Allen Stering, Junne Kamihara, Cynthia E. Herzog, Anne K. Harris et al.
3 citations
Cancer
Ovarian cancer diagnosis and treatment
5.09
article

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries

Allen Stering, Junne Kamihara, Cynthia E. Herzog, Anne K. Harris, Alexander T. Nelson, D. Ashley Hill, Carolyn Fein Levy, Kenneth Chen, Joanne Lagmay, Jennifer N. Stall, Kris Ann P. Schultz, Louis P. Dehner, Anil K. Tadavarthy, Stacy L. Snyder, A. Lindsay Frazier, Kyle M. Devins, Yoav H. Messinger, Steve Foresto, Dominik T. Schneider, Deborah F. Billmire, Robert H. Young, Paige Mallinger, Dave Watson
article en
3 citations

Abstract

Outcomes were worse for patients with FIGO stage ≥IC2 disease and for tumors with >19 mitoses per 10 HPF. Given the prognostic significance of MI, the authors strongly recommend the assessment of MI for all juvGCTs. More information about tumor biology is critical to identify which patients may benefit from adjuvant chemotherapy and to facilitate the development of novel therapies.

CancerVol. 131(9)
Children's Medical Center (US), Northwell Health (US), Beth Israel Deaconess Medical Center (US), Children’s Institute (US), National Marrow Donor Program (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Witten/Herdecke University (DE), Washington University in St. Louis (US), Walter Reed National Military Medical Center (US), University of Florida (US), Beacon Health System (US), Massachusetts General Hospital (US), Center for Cancer and Blood Disorders (US), Children's Minnesota (US), Mayo Clinic in Florida (US), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), Children's Health Queensland Hospital and Health Service (AU), Southwestern Medical Center (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 5%
Ovarian cancer diagnosis and treatment
5.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.